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Abstract Phosphoprotein associated with GEMs (PAG), also
known as Csk-binding protein (Cbp), is a broadly expressed
palmitoylated transmembrane adapter protein found in mem-
brane rafts, also called GEMs (glycosphingolipid-enriched
membrane microdomains). PAG is known to bind and activate
the essential regulator of Src-family kinases, cytoplasmic protein
tyrosine kinase Csk. In the present study we used the yeast 2-
hybrid system to search for additional proteins which might bind
to PAG. We have identified the abundant cytoplasmic adapter
protein EBP50 (ezrin/radixin/moesin (ERM)-binding phospho-
protein of 50 kDa), also known as NHERF (Na+/H+ exchanger
regulatory factor), as a specific PAG-binding partner. The
interaction involves the C-terminal sequence (TRL) of PAG and
N-terminal PDZ domain(s) of EBP50. As EBP50 is known to
interact via its C-terminal domain with the ERM-family
proteins, which in turn bind to actin cytoskeleton, the PAG^
EBP50 interaction may be important for connecting membrane
rafts to the actin cytoskeleton. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Phosphoprotein associated with GEMs (PAG) [1], also
known as Csk-binding protein (Cbp) [2] is a broadly ex-
pressed, palmitoylated transmembrane adapter protein
present in glycosphingolipid-enriched membrane microdo-
mains (GEMs; also known as membrane rafts). PAG binds
(via phosphorylated Tyr-317) the protein tyrosine kinase
(PTK) Csk, a major negative regulator of Src-family kinases
[1,2], and thus acts as a ‘co-factor’ helping to bring the cyto-
plasmic PTK Csk to the membrane microdomains rich in its
substrates, the Src-family kinases. In addition, the formation
of the PAG^Csk complex apparently increases the Csk activ-
ity also via a conformational mechanism [3]. Thus, the PAG^
Csk complex suppresses the activity of membrane-associated
Src-family kinases which is probably important in regulation
of essential cellular functions such as growth and receptor
signaling. It was demonstrated that ligation of the T-cell re-
ceptor (TCR)/CD3 complex by agonistic antibodies is accom-
panied by transient tyrosine dephosphorylation of PAG and
release of Csk, which may help to increase the activity of Src-
kinases (namely Lck and Fyn) during the early phases of T-
cell activation [1].
In the present study we used the yeast 2-hybrid (Y2H)
system to search for additional proteins which might interact
with the cytoplasmic domain of PAG.
2. Materials and methods
2.1. Cells and transfectants
Wild-type MDCK cells (canine kidney epithelial; provided by Dr.
H. Stockinger, University of Vienna) were maintained in Dulbecco’s
modi¢ed Eagle’s medium (DMEM) supplemented with 10% heat-in-
activated fetal calf serum (FCS) at 37‡C in 5% CO2. To produce
stable transfected cell lines, cDNAs coding for either PAG or PAG
lacking the C-terminal sequence TRL (vPAG) were cloned to pE-
FIRES expression vector [4]. These constructs were transfected into
the MDCK cells using LipofectAMINE reagent (Life Technologies).
Transfectants were selected for G418 resistance and cloned by limiting
dilution; positive clones were selected by Western blotting and main-
tained in DMEM supplemented with G418 (800 Wg/ml, potency s 450
Wg/mg). Human adenocarcinoma Caco-2 cells (provided by Dr. L.
Tuc'kova¤, Institute of Microbiology AS CR, Prague, Czech Republic)
were maintained in Eagle’s minimum essential medium supplemented
with 20% heat-inactivated FCS and 0.1 mM non-essential amino
acids. Human T-cell line Jurkat and B-cell line Raji were maintained
in RPMI medium containing 10% FCS. Human peripheral blood
KLT-cells were prepared from bu¡y coats by cell sorting [1].
2.2. Reagents, antibodies and recombinant proteins
If not stated otherwise, the reagents used were from Sigma. Mouse
monoclonal antibodies (mAbs) against the cytoplasmic part of human
PAG were produced as described earlier [1]. Mouse mAb against
ezrin^radixin^moesin (ERM)-binding phosphoprotein 50 kDa
(EBP50 (EBP-10; IgG2b)) was produced by standard procedures
from Balb/c mouse immunized with recombinant EBP50. Rabbit
anti-serum against human EBP50 cross-reactive with the canine ho-
molog, bacterially produced His-tagged full-length EBP50, gluta-
thione-S-transferase (GST)-PDZ1 and -PDZ2 domains of EBP50
were described elsewhere [5,6]. A GST^ezrin construct (residues 1^
296) was generated by polymerase chain reaction (PCR) using human
kidney cDNA as a template and the PCR product was subcloned in-
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frame into pGEX-5x-2. The insert was veri¢ed by DNA sequencing
and the construct was used for bacterial expression.
2.3. Y2H cDNA library screening for proteins interacting with PAG
The cytoplasmic part of PAG (amino acids 192^432) was subcloned
into the Y2H plasmid pGBKT7 (Clontech), transformed into the
yeast strain AH109 and used as a ‘bait’ in a Y2H screening of the
human leukocyte MATCHMAKER cDNA library (Clontech) trans-
formed in the yeast strain Y187 performed by yeast mating according
to the manufacturer’s instructions.
2.4. Membrane preparation
Cells (2U108) were resuspended in 1 ml of ice-cold hypotonic bu¡er
(10 mM HEPES pH 7.4, 42 mM KCl, 5 mM MgCl2, 1 mM AEBSF,
10 mM EDTA), incubated on ice for 15 min and then passed 10U
through the 25-gauge needle. NaF and Na3VO4 (10 and 1 mM ¢nal
concentrations, respectively) were added after the cell disruption and
the suspension was centrifuged for 5 min at 400Ug and 0‡C to re-
move nuclei. The ice-cold post-nuclear supernatants were centrifuged
for 10 min at 18 000Ug and 0‡C to pellet the membranes.
2.5. Immunoprecipitation experiments
Cells or membranes were solubilized in isotonic lysis bu¡er (Tris-
bu¡ered saline pH 8.2, containing 1 mM AEBSF, 10 mM EDTA, 10
mM NaF, 1 mM Na3VO4 and 1% detergent laurylmaltoside (n-do-
decyl L-D-maltoside; Calbiochem)) and post-nuclear supernatants
were used for immunoprecipitations essentially as described before
[1] using Protein A-puri¢ed mAbs covalently coupled to CNBr^
Sepharose beads (AP Biotech) as immunosorbents. Immunoisolation
was performed using minicolumns (50 Wl packed volume) of immuno-
sorbent. Post-nuclear cell or membrane lysates were passed through
the columns; after washing with 10 column volumes of the lysis bu¡-
er, bound proteins were eluted with 2 column volumes of 2U concen-
trated non-reducing Laemmli sample bu¡er and the £ow-through and
eluted fractions were analyzed by sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE) followed by Western blotting.
In some experiments, GST-tagged ezrin bound to Glutathione Sephar-
ose 4B (AP Biotech) was used for an a⁄nity isolation of EBP50. In
this case minicolumns packed with 50 Wl of Glutathione Sepharose 4B
either loaded with 2 Wg of recombinant GST^ezrin or unloaded were
used to isolate EBP50 from the membrane lysate as described above.
2.6. Ligand blotting
PAG immunoprecipitates were subjected to SDS^PAGE followed
by electroblotting onto PVDF membrane and standard immunoper-
oxidase staining with rabbit anti-EBP50 anti-serum. The blot was then
reprobed with the recombinant EBP50 PDZ1 or PDZ2 domains (20
Wg/ml in phosphate-bu¡ered saline (PBS), 0.05% Tween 20, 0.5% non-
fat dry milk) followed by rabbit anti-EBP50 anti-serum and horse-
radish peroxidase-conjugated secondary antibody.
2.7. Fractionation of detergent-resistant GEMs (membrane rafts) by
density gradient ultracentrifugation
Cells (5U106 Jurkat cells or MDCK cells obtained from one con-
£uent 10-cm culture dish) were washed in PBS, resuspended in 500 Wl
of ice-cold lysis bu¡er containing 3% detergent Brij-58 and lysed 30
min on ice. The lysate was mixed 1:1 with 80% (w/v) sucrose in lysis
bu¡er and placed at the bottom of a 5.2 ml polyallomer centrifuge
tube (Beckman Instruments), then carefully overlaid with 3.5 ml of
30% (w/v) sucrose in lysis bu¡er and ¢nally with 1 ml of lysis bu¡er.
Centrifugation was performed at 2‡C in Beckman SW55Ti rotor (18
h, 52 000 rpm). Eight 0.63 ml fractions were collected gradually from
the top of the gradient, proteins were separated by SDS^PAGE and
analyzed by immunoblotting.
3. Results
3.1. Identi¢cation of EBP50 as a potential binding partner of
PAG by Y2H
The Y2H screening of human leukocyte cDNA library was
performed using the c-terminal part of the cytoplasmic do-
main of PAG (amino acids 192^432) as a ‘bait’. Out of ap-
proximately 2 million transformants, roughly 200 colonies
grew in the selective media lacking adenosine and histidine
and were positive in the L-galactosidase assay. Among these,
more than 70 clones contained various parts of EBP50, also
known as NHERF (Na/H exchanger regulatory factor)
[7,8]. EBP50 did not interact with the control bait
pGBKT7-lamin or with the empty vector pGBKT7, docu-
menting the speci¢city of its interaction with PAG (not
shown). EBP50 is an abundant cytoplasmic protein containing
two N-terminal PDZ domains and a C-terminal domain
which is known to bind to the ERM-family proteins [8].
The PDZ1 domain of EBP50 was previously demonstrated
to bind to the C-terminal Thr-Arg-Leu-COOH (TRL) motif
of several membrane proteins including the cystic ¢brosis
transmembrane conductance regulator (CFTR) [6,9,10]; this
interaction may target CFTR to the apical surface of epithe-
lial cells [11]. Importantly, the C-terminal TRL motif is also
present in PAG, thus rationalizing the result of the Y2H
screening.
3.2. The PAG^EBP50 interaction occurs in mammalian cells
MDCK cells transfected with human PAG or PAG lacking
the C-terminal TRL sequence (vPAG) were solubilized in a
solution of 1% laurylmaltoside, a detergent disrupting GEMs,
and the lysates were subjected to immunoprecipitation on an
anti-PAG immunosorbent. Western blotting analysis of the
immunoprecipitates demonstrated co-precipitation of endoge-
nous EBP50 with PAG from the transfectants containing the
wild-type human PAG but not vPAG (Fig. 1A). Similarly, a
speci¢c co-precipitation of EBP50 with endogenous PAG
could be demonstrated from detergent lysates of peripheral
blood T-cells, wild-type Raji, Jurkat and Caco-2 cells (Fig.
Fig. 1. Co-precipitation of EBP50 with PAG. A: Wild-type MDCK
cells (MDCK WT) were stably transfected with human PAG
(MDCK PAG) or PAG lacking the last three C-terminal amino
acids (MDCK vPAG). Detergent (1% laurylmaltoside) lysates of
these cells were immunoprecipitated on an anti-PAG immunosorb-
ent and the immunoprecipitates were analyzed by immunoblotting.
mAb MEM-255 and rabbit anti-serum to EBP50 were used to de-
tect human PAG and endogenous EBP50, respectively. B: Immuno-
precipitation (IP) of detergent lysates of the indicated human cells
was performed on anti-PAG or irrelevant control (CTR) immuno-
sorbents and the speci¢cally co-precipitated EBP50 was detected as
in A.
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1B). The membrane with the electroblotted PAG or vPAG
immunoprecipitates obtained from the MDCK transfectants
was further used to demonstrate direct binding of EBP50
PDZ1 domain to PAG using the ligand-blotting approach
(Fig. 2). The same results were obtained when PDZ2 domain
was used (not shown); this would indicate that PAG may
interact with EBP50 through any of the two PDZ domains.
The results of quantitative immunoisolation of PAG indicated
that only a minor fraction of EBP50 is associated with PAG
(not shown). Speci¢c interaction between PAG and EBP50
could also be demonstrated by a reciprocal co-precipitation
of PAG from detergent solubilized Raji cell membranes on an
anti-EBP50 immunosorbent (Fig. 3A); a similar result was
also obtained when immobilized GST^ezrin was used to af-
¢nity isolate EBP50 from detergent solubilized Jurkat cell
membranes: as expected, all EBP50 present in this lysate
was bound to immobilized ezrin and a minor fraction of total
PAG was co-isolated under these conditions (Fig. 3B).
3.3. A fraction of EBP50 is present in GEMs
A major fraction of PAG is present in GEMs, buoyant
microdomains enriched in glycosphingolipids and cholesterol,
resistant to solubilization by detergents such as Triton X-100,
NP40 or Brij-58 [1,2]. Therefore, we examined whether a frac-
tion of EBP50, which has no known structural features target-
ing it to GEMs (such as the lipid modi¢cations present in
PAG or in Src-family PTKs) can be, due to its interaction
with PAG, also detected in such large, buoyant, detergent-
resistant complexes. Indeed, a markedly larger fraction of
EBP50 could be detected in the typical GEMs-containing su-
crose density gradient ultracentrifugation fractions of MDCK
cells transfected with human PAG as compared to wild-type
MDCK cells ; a minor fraction of EBP50 could be demon-
strated also in the GEMs of wild-type Jurkat cells (Fig. 4).
4. Discussion
Our data demonstrate that, in addition to Csk, EBP50 is
another protein interacting with the transmembrane adapter
protein PAG. This interaction, dependent on the PAG C-ter-
minal motif suitable for binding to the PDZ domains of
EBP50, was detected ¢rst by means of the Y2H system and
was subsequently con¢rmed by co-isolation from detergent
lysates of mammalian cells and also by ligand blotting.
PAG is a characteristic component of GEMs, the mem-
brane structures known to be important in immunoreceptor
Fig. 2. Demonstration of direct interaction between PAG and
EBP50 PDZ1 domain by ligand blotting. The same blots as shown
in Fig. 1A were incubated with recombinant GST-PDZ1 domain;
the zones containing EBP50 or the PDZ1 domain were then visual-
ized by anti-EBP50 immunoperoxidase staining. Thus, the 50 kDa
zone corresponding to the co-precipitated EBP50 was immuno-
stained directly, while the zone corresponding by size exactly to
PAG was visualized due to the binding of the PDZ1 domain to the
membrane-immobilized PAG.
Fig. 3. Co-precipitation of PAG on anti-EBP50 immunosorbent and
on immobilized ezrin. A: Detergent lysate of Raji cell membranes
was immunoprecipitated on an anti-EBP50 immunosorbent (EBP50)
or immobilized irrelevant control mAb (CTR). The original lysate
(Lysate) and immunoprecipitates (IP) were analyzed by SDS^PAGE
and immunoblotting as in Fig. 1A. B: Detergent lysate of Jurkat
cell membranes was used for a⁄nity isolation of EBP50 on immobi-
lized GST^ezrin (+) and control glutathione^Sepharose (3). The
original lysate (Lysate), materials passed through the sorbent mini-
columns (Flow through) and materials eluted from the sorbents
(Isolated) were analyzed by SDS^PAGE and immunoblotting as in
Fig. 1A.
Fig. 4. The presence of EBP50 in GEMs (membrane rafts). MDCK
cells transfected with human PAG (MDCK PAG), wild-type
MDCK cells (MDCK wt) or Jurkat cells were detergent solubilized
and fractionated by density gradient ultracentrifugation as described
in Section 2.7. The fractions (numbered from the top to the bottom
of the gradient) were analyzed by SDS^PAGE and immunoblotting
as in Fig. 1A.
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signaling. GEMs redistribute to the site of contact between an
antigen-presenting cell and a T-cell ; the interaction between
activated TCR and GEMs, which is crucial for initiation of
the signaling cascades, is accompanied or perhaps even caused
by actin cytoskeleton redistribution [12]. Similarly, function-
ally important interactions between the high a⁄nity FcO-re-
ceptor and lipid rafts on activated mastocytes are dependent
on actin cytoskeleton [13]. Thus, it may be hypothesized that
the complex formed between PAG and EBP50 may help to
link GEMs to F-actin (via the ERM proteins), which might be
essential for redistribution of GEMs during immunoreceptor
signaling.
Our data suggest that only a minor fraction of total PAG is
associated with EBP50 and vice versa. A simple reason for
this could be a relatively low a⁄nity of this interaction which
may cause a rapid dissociation of the complex following cell
lysis and during immunoisolation; if so, our results would
simply underestimate the real amount of the complex in
vivo. The relatively low a⁄nity of the PAG^EBP50 interac-
tion could be due to a suboptimal structure of the PAG C-
terminus for binding to the EBP50 PDZ domains. Although
the minimal consensus sequence for binding to both PDZ1
and PDZ2 domains of EBP50 is S/T-x-L, the nature of the
amino acid at the 34 position may also play a role [9,10].
Another possibility for the observed low stoichiometry of the
PAG^EBP50 interaction is that major fractions of PAG or
EBP50 (or both) are in vivo modi¢ed in a way interfering with
the interaction. Such modi¢cations might include, for exam-
ple, phosphorylation of the threonine residue within the TRL
sequence proteolytic truncation of PAG at the C-terminus or
folding of native PAG molecule such that the C-terminus is
not accessible for interaction with the PDZ domains. How-
ever, these modi¢cations seem unlikely because our mAbs
speci¢cally reactive with the unmodi¢ed C-terminal peptide
of PAG immunoprecipitate PAG essentially quantitatively
(unpublished results). Also, a covalent modi¢cation or a con-
formational arrangement of a major fraction of EBP50 might
prevent its binding to PAG.
In any case, even the small amounts of the PAG^EBP50
complex (compared to the total amounts of PAG and EBP50
in the cells) may be su⁄cient to link GEMs (membrane rafts)
to the cytoskeleton. We are currently examining possible
quantitative changes in the PAG^EBP50 complex induced
by various cell activation treatments potentially inducing its
link to ezrin-family proteins and F-actin.
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